https://www.selleckchem.com/products/1-nm-pp1.html
From within year-five to within year-one prior to the index, the median duration of oral corticosteroid treatment increased from 34 to 88days per year and the proportion of patients who experienced more extensive/pancolitis disease increased from 16 to 59%. Overall, the frequency of all-cause health care visits also increased. Patients with UC experienced increasing morbidity and treatment burden in the 5years prior to initiating biologic therapy. To achieve reduced corticosteroids in UC management, better risk stratification is needed